Evidence map›Paper›PMID 21383264›Full record

ArticleArchives of general psychiatry2011

Gene x disease interaction on orbitofrontal gray matter in cocaine addiction.

Nelly Alia-Klein, Muhammad A Parvaz, Patricia A Woicik, Anna B Konova, Thomas Maloney, Elena Shumay, Ruiliang Wang, Frank Telang, Anat Biegon, Gene-Jack Wang and 4 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Archives of general psychiatry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. RBFOX1, encoding a splicing regulator, is a candidate gene for aggressive behavior.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Nelly Alia-KleinMedical Department, Brookhaven National Laboratory, Upton, NY 11973-5000, USA. nellyklein@bnl.gov
Muhammad A Parvaz
Patricia A Woicik
Anna B Konova
Thomas Maloney
Elena Shumay
Ruiliang Wang
Frank Telang
Anat Biegon
Gene-Jack Wang
Joanna S Fowler
Dardo Tomasi
Nora D Volkow
Rita Z Goldstein
Icahn School of Medicine at Mount Sinai · USStony Brook University · USBrookhaven National Laboratory · USNational Institute on Drug Abuse · US

Funding

Neurobiology of Substance Abuse and AddictionZIAAA000550 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI VOLKOW, NORA D. · 2009 to 2025
$115.1M
The prefrontal cortex in salience and control in cocaine addiction: phFMRI studyR01DA023579 · NIDA · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI GOLDSTEIN, RITA Z · 2008 to 2012
$2.8M
DOPAMINERGIC BRAIN FUNCTION IN ALCOHOLICSR01AA009481 · NIAAA · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI WANG, GENE-JACK · 1993 to 2007
$2.7M
NIAAA NIH HHS 2R01AA09481NIAAA NIH HHS R01 AA009481NIDA NIH HHS R01 DA023579NIDA NIH HHS R01DA023579NIDA NIH HHS R21DA02062
6 · The paper itself

Abstract

contextLong-term cocaine use has been associated with structural deficits in brain regions having dopamine-receptive neurons. However, the concomitant use of other drugs and common genetic variability in monoamine regulation present additional structural variability.

objectiveTo examine variations in gray matter volume (GMV) as a function of lifetime drug use and the genotype of the monoamine oxidase A gene, MAOA, in men with cocaine use disorders (CUD) and healthy male controls.

designCross-sectional comparison.

settingClinical Research Center at Brookhaven National Laboratory. PATIENTS: Forty individuals with CUD and 42 controls who underwent magnetic resonance imaging to assess GMV and were genotyped for the MAOA polymorphism (categorized as high- and low-repeat alleles).

main outcome measuresThe impact of cocaine addiction on GMV, tested by (1) comparing the CUD group with controls, (2) testing diagnosis × MAOA interactions, and (3) correlating GMV with lifetime cocaine, alcohol, and cigarette smoking, and testing their unique contribution to GMV beyond other factors.

results(1) Individuals with CUD had reductions in GMV in the orbitofrontal, dorsolateral prefrontal, and temporal cortex and the hippocampus compared with controls. (2) The orbitofrontal cortex reductions were uniquely driven by CUD with low- MAOA genotype and by lifetime cocaine use. (3) The GMV in the dorsolateral prefrontal cortex and hippocampus was driven by lifetime alcohol use beyond the genotype and other pertinent variables.

conclusionsLong-term cocaine users with the low-repeat MAOA allele have enhanced sensitivity to gray matter loss, specifically in the orbitofrontal cortex, indicating that this genotype may exacerbate the deleterious effects of cocaine in the brain. In addition, long-term alcohol use is a major contributor to gray matter loss in the dorsolateral prefrontal cortex and hippocampus, and is likely to further impair executive function and learning in cocaine addiction.

Indexed as

AllelesImage Processing, Computer-AssistedMagnetic Resonance ImagingAdultAlcoholismAtrophyBrainCocaineCocaine-Related DisordersDopamineDopamine Uptake InhibitorsFrontal LobeGenetic Predisposition to DiseaseGenotypeHippocampusHumansCocaineDopamineDopamine Uptake InhibitorsMonoamine Oxidase

Identifiers

PMID21383264
PMCPMC3127452
OpenAlexW2134849616

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.